Discrepancies in Adverse Event Reporting Between ClinicalTrials.gov and Publications in HIV/AIDS Clinical Trials: A Pre-Post Analysis of the FDAAA Final Rule

Ryan Langerman, Graham N Jameison, Logan Corwin, Daniel Archer, Kellen Keefer, Rachel Hazlitt, Tag Harris, Alicia Ito Ford, Matt Vassar

Open source

DOI
10.2147/clep.s608444
Published
2026-10
Container
Clinical Epidemiology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/clep.s608444,
  title = {Discrepancies in Adverse Event Reporting Between ClinicalTrials.gov and Publications in HIV/AIDS Clinical Trials: A Pre-Post Analysis of the FDAAA Final Rule},
  author = {Ryan Langerman and Graham N Jameison and Logan Corwin and Daniel Archer and Kellen Keefer and Rachel Hazlitt and Tag Harris and Alicia Ito Ford and Matt Vassar},
  year = {2026},
  journal = {Clinical Epidemiology},
  doi = {10.2147/clep.s608444},
  url = {https://doi.org/10.2147/clep.s608444}
}

RIS

TY  - JOUR
TI  - Discrepancies in Adverse Event Reporting Between ClinicalTrials.gov and Publications in HIV/AIDS Clinical Trials: A Pre-Post Analysis of the FDAAA Final Rule
AU  - Ryan Langerman
AU  - Graham N Jameison
AU  - Logan Corwin
AU  - Daniel Archer
AU  - Kellen Keefer
AU  - Rachel Hazlitt
AU  - Tag Harris
AU  - Alicia Ito Ford
AU  - Matt Vassar
PY  - 2026
JO  - Clinical Epidemiology
DO  - 10.2147/clep.s608444
UR  - https://doi.org/10.2147/clep.s608444
ER  - 

APA

Langerman, R., Jameison, G. N., Corwin, L., Archer, D., Keefer, K., Hazlitt, R., Harris, T., Ford, A. I., & Vassar, M. (2026). Discrepancies in Adverse Event Reporting Between ClinicalTrials.gov and Publications in HIV/AIDS Clinical Trials: A Pre-Post Analysis of the FDAAA Final Rule. Clinical Epidemiology. https://doi.org/10.2147/clep.s608444

Source records